期刊文献+

高效液相色谱法手性拆分N-叔丁氧羰基-3-羟基-1-金刚烷甘氨酸对映体 被引量:5

Chiral resolution of N-boc-3-hydroxyadamantylglycine by HPLC
下载PDF
导出
摘要 建立一种使用多糖衍生物类手性色谱柱拆分N-叔丁氧羰基-3-羟基-1-金刚烷甘氨酸对映体的正相高效液相色谱方法,为实现通过拆分方法制备该化合物单一对映体的过程控制提供依据.采用手性色谱柱Chiralpak ID在正相液相色谱条件下拆分该对映体,通过考察流动相比例、柱温、流速对对映体分离效果的影响,得到最佳拆分条件为:以V(正己烷)∶V(乙醇)=85∶15为流动相,流速0.8mL/min,检测波长220nm,柱温30℃.可使N-叔丁氧羰基-3-羟基-1-金刚烷甘氨酸对映体达到基线分离,分离度达3.72.该方法准确可靠,灵敏度高,重现性好,可用于该对映体的手性拆分. An immobilized chiral column was used to establish a normal phase HPLC method for the enantiometric separation of racemic N-boc-3-hydroxyadamantylglycine. It provides a basis for the process control of the preparation of monoenantiotropic N-boc-3-hydroxyadamantylglycine by chiral resolution. The chiral separation of enantionmer was achieved by using a Chiralpak ID immobilized chiral column. The mobile phase was consisted of V(n-hexane) : V(ethanol)= 85 : 15 at a flow rate of 0.8 mL/min, the column temperature was kept at 30 ℃, and the wavelength was set at 220 nm. The enantionmer resolution was successfully conducted with a resolution value of 3. 72. This method is accurate, reliable, sensitive and available for the enantiometric separation of racemic N-boc-3-hydroxyadamantylglycine.
出处 《浙江工业大学学报》 CAS 北大核心 2015年第3期298-301,共4页 Journal of Zhejiang University of Technology
基金 浙江省省级公益性技术应用研究计划项目(2014C33274)
关键词 N-叔丁氧羰基-3-羟基-1-金刚烷甘氨酸 高效液相 手性拆分 N-boe-3-hydroxyadamantylglycine HPLC chiral separation
  • 相关文献

参考文献14

二级参考文献130

  • 1曹雪玲,刘发现,金东日,王清珊,李熔一.手性固定相反相高效液相色谱法分析普萘洛尔对映体[J].分析试验室,2007,26(z1):330-333. 被引量:5
  • 2刘雪英 ,王庆伟 ,李晓晔 ,张生勇 .高效液相色谱手性固定相拆分酒石酸美托洛尔对映体条件的优化[J].解放军药学学报,2005,21(3):186-188. 被引量:6
  • 3黄善定,方海飞.手性药物拆分的研究进展[J].医药导报,2005,24(8):710-712. 被引量:12
  • 4纪媛媛,袁牧,白宝清.ChiralcelOD-RH手性柱拆分卡维地洛对映体[J].分析测试学报,2007,26(4):585-586. 被引量:7
  • 5PAN Chunxiu, SHEN Baoehun, XU Beijia,et. al. Comparative enantioseparation of seven triazole fungicide on (S, S)- Whelk O1 and four different cellulose derivative columns[J]. Journal of Separation Science,2006,29(3):2004-2011.
  • 6WILD S, ROGLIC G, GREEN A, et al. Global prevalence of diabetes : estimates for the year 2000 and projections for 2030[J]. Diabetes Care 2004, 27(5) : 1047-1053.
  • 7KNOWLER WC, BARRETY-CONNOR E, FOWLER SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin[J]. N Engl J Med, 2002, 346 (6): 393-403.
  • 8TUOMILEHTO J, LINDSTROM J, ERIKSSON JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance [J]. N Engl J Med, 2001, 344(18): 1343-1350.
  • 9GERSTEIN HC, YUSUF S, BOSCH J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial [J]. Lancet, 2006, 368 (9541): 1096-1105.
  • 10MOORE KB, SAUDEK CD. Therapeutic potential of dipeptidyl peptidase-IV inhibitors in patients with diabetes mellitus[J]. Am J Ther, 2008, 15(5): 484-491.

共引文献71

同被引文献80

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部